Skip to main content
Lawrence Hirsch, MD, Neurology, New Haven, CT, Yale-New Haven Hospital

LawrenceJamesHirschMD

Neurology New Haven, CT

Epilepsy, Neurophysiology

Professor of Neurology; Chief, Division of Epilepsy/EEG; Yale University

Dr. Hirsch is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hirsch's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital -  Columbia Campus
    New York Presbyterian Hospital - Columbia CampusResidency, Neurology, 1992 - 1995
  • Yale-New Haven Hospital
    Yale-New Haven HospitalInternship, Internal Medicine, 1991 - 1992
  • Yale University School of Medicine
    Yale University School of MedicineClass of 1991

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2011 - 2022
  • NY State Medical License
    NY State Medical License 1994 - 2022
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Clinical Neurophysiology
  • American Board of Psychiatry and Neurology Epilepsy

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Assessment of a Study of Continuous vs Repeat-Spot Electroencephalography in Patients with Critical Illness  
    Lawrence Hirsch, MD, JAMA Neurology
  • Prevalence and Predictors of Seizure Clusters: A Prospective Observational Study of Adult Patients with Epilepsy  
    Kamil Detyniecki, Lawrence J Hirsch, Epilepsy & Behavior

Lectures

  • Neurology Update and Stroke Intensive 2012 
    Univesity of Miami Leonard M. Miller School of Medicine, Coconut Grove, Florida - 1/26/2012

Other

Press Mentions

  • Marinus Pharma Shares Open up 41% on Phase 2 Epilepsy Trial Results
    Marinus Pharma Shares Open up 41% on Phase 2 Epilepsy Trial ResultsSeptember 30th, 2019
  • Nonconvulsive Seizures and Nonconvulsive Status Epilepticus in the Neuro ICU Should or Should Not Be Treated Aggressively: A Debate
    Nonconvulsive Seizures and Nonconvulsive Status Epilepticus in the Neuro ICU Should or Should Not Be Treated Aggressively: A DebateAugust 9th, 2019
  • EEG Can Help Predict Neurologic Outcomes After Cardiac Arrest
    EEG Can Help Predict Neurologic Outcomes After Cardiac ArrestAugust 8th, 2019
  • Join now to see all

Hospital Affiliations